Athersys was founded in 1995 and is headquartered in Cleveland, US
Report incorrect company information
Key People/Management at Athersys
Gil Van Bokkelen
Chairman & CEO
William Lehmann Jr
President, COO
John Harrington
Executive Vice President and Chief Scientific Officer
Laura Campbell
Controller
Manal Morsy
Vice President, Global Regulatory Affairs
Report incorrect company information
Athersys Office Locations
Athersys has offices in Canton and Cleveland
Cleveland, US (HQ)
3201 Carnegie Ave
Canton, US
250 Royall St
Report incorrect company information
Athersys Financials and Metrics
Athersys Financials
Athersys's revenue was reported to be $3.71 m in FY, 2017
| USD | |
|---|---|
Revenue (Q1, 2018) | 1.1 m |
EBIT (Q1, 2018) | (10.3 m) |
Market capitalization (14-Jun-2018) | 321.4 m |
Closing share price (14-Jun-2018) | 2.3 |
Cash (31-Mar-2018) | 49.7 m |
Athersys's current market capitalization is $321.4 m.
- Source: SEC Filings
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 621 k | 707 k | 388 k | 293 k | 731 k | 216 k | 396 k | 15.5 m | 595 k | 311 k | 1.5 m | 669 k | 1.1 m |
General and administrative expense | 1.5 m | 1.8 m | 1.8 m | 1.7 m | 1.9 m | 1.9 m | 1.9 m | 2 m | 2 m | 1.8 m | 2.1 m | 2.2 m | 2.7 m |
R&D expense | 4.7 m | 6.2 m | 5.8 m | 5.8 m | 5.7 m | 5.3 m | 5.1 m | 6.7 m | 5.8 m | 5.3 m | 5.6 m | 4.6 m | 8.9 m |
Operating expense total | 6.2 m | 8.1 m | 7.7 m | 7.6 m | 7.6 m | 7.3 m | 7.1 m | 8.7 m | 7.9 m | 7.2 m | 7.9 m | 7 m | 11.7 m |
- Source: SEC Filings
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 17.8 m | 45 m | 38.8 m | 32.4 m | 35.5 m | 32.3 m | 28.5 m | 30.4 m | 13.8 m | 8.3 m | 31.9 m | 28.6 m | 49.7 m |
Accounts Receivable | 453 k | 894 k | 715 k | 665 k | 298 k | 1.8 m | 759 k | ||||||
Current Assets | 18.6 m | 46.2 m | 39.8 m | 33.4 m | 38.7 m | 35.1 m | 29.2 m | 31.5 m | 25.7 m | 20.5 m | 34.9 m | 30.1 m | 58.4 m |
Total Assets | 19.9 m | 47.6 m | 41.1 m | 34.8 m | 40.2 m | 36.5 m | 30.6 m | 33 m | 27.9 m | 23.3 m | 37.6 m | 32.7 m | 60.9 m |
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q1, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (5.6 m) | (10.2 m) | ||||||||||
Depreciation and Amortization | 86 k | 89 k | 93 k | 91 k | 70 k | 65 k | 66 k | 68 k | 67 k | 114 k | 164 k | 186 k |
Accounts Payable | 2.8 m | 2.9 m | 2.7 m | 2.3 m | 2.6 m | 3.3 m | 4.2 m | 3.6 m | 6.6 m | 2 m | ||
Cash From Operating Activities | (5.7 m) |
| USD | Y, 2018 |
|---|---|
Financial Leverage | 1.3 x |
Athersys Operating Metrics
Athersys's Patent Applications was reported to be 170 in FY, 2016.
| FY, 2016 | |
|---|---|
Patent Applications | 170 |
Patents (US) | 21 |
Patents Issued | 200 |
Report incorrect company information
Athersys Online and Social Media Presence
Report incorrect company information
Athersys News and Updates
June 11, 2018
Innovative Biotech Companies Pushing the Envelope
LAS VEGAS, June 11, 2018 /PRNewswire/ --
FN Media Group Presents Microcapspeculators.com News Commentary
Innovation has always been the name of the game when it comes to biotechnology. It seems with each passing year that more and more new innovative treatments are being conside...
May 24, 2018
Trauma Trial Boosts Athersys's Allure
Report incorrect company information